MTAP and cancer: Although not yet tested in GEP-NENs, loss of the enzyme methylthioadenosine phosphorylase (MTAP) due to genetic deletion of the nearby CDKN2A tumor suppressor may confer dependence on PRMT5 arginine methyltransferase activity as happens in other cancers (114).